Inactive Instrument

Analyst Reco. NextGen Healthcare, Inc.

Equities

NXGN

US65343C1027

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Truist Securities Adjusts Price Target on NextGen Healthcare to $23.95 From $18, Maintains Hold Rating	23-09-08	MT
Cantor Fitzgerald Downgrades NextGen Healthcare to Neutral From Overweight, Raises Price Target to $23.95 From $21	23-09-07	MT
Deutsche Bank Adjusts NextGen Healthcare Price Target to $24 From $21, Maintains Hold Rating	23-09-07	MT
RBC Raises Price Target on NextGen Healthcare to $23.95 From $17, Announces Acquisition by Thoma Bravo, Keeps Sector Perform Rating	23-09-07	MT
Guggenheim Downgrades NextGen Healthcare to Neutral From Buy	23-09-06	MT
Piper Sandler Adjusts NextGen Healthcare Price Target to $23.95 From $17, Maintains Neutral Rating	23-09-06	MT
Stephens Downgrades NextGen Healthcare to Equal Weight From Overweight, Trims Price Target to $23.95 From $24	23-09-06	MT
Cantor Fitzgerald Starts NextGen Healthcare at Overweight With $21 Price Target	23-08-28	MT
Baptista Research Initiates NextGen Healthcare at Buy Rating, $21.90 Price Target	23-08-24	MT
RBC Cuts Price Target on NextGen Healthcare to $17 From $19, Cites Peer Multiple Compression, Keeps Sector Perform Rating	23-06-12	MT
Guggenheim Adjusts Price Target on NextGen Healthcare to $22 From $26, Keeps Buy Rating	23-05-23	MT
Truist Securities Adjusts Price Target on NextGen Healthcare to $18 From $22, Maintains Hold Rating	23-05-22	MT
Piper Sandler Adjusts Price Target on NextGen Healthcare to $17 From $20, Maintains Neutral Rating	23-05-18	MT
Stephens Initiates NextGen Healthcare at Overweight With $24 Price Target	23-04-12	MT
Deutsche Bank Adjusts NextGen Healthcare Price Target to $21 From $20, Maintains Hold Rating	23-01-26	MT
SVB Securities Raises NextGen Healthcare's Price Target to $25 From $24, Keeps Outperform Rating	22-10-26	MT
Piper Sandler Assumes NextGen Healthcare at Neutral with $20 Price Target	22-10-21	MT
Truist Securities Initiates NextGen Healthcare at Hold With $20 Price Target	22-09-07	MT
SVB Leerink Adjusts NextGen Healthcare's Price Target to $24 from $22, Keeps Outperform Rating	22-05-04	MT
Guggenheim Initiates NextGen Healthcare With Neutral Rating	22-04-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. NextGen Healthcare, Inc.

Equities

NXGN

US65343C1027

Analyst Reco.

Filters